Innovations in Implantable Pulse Generator Design: Engineering Challenges and Solutions for Next-generation Neuromodulation
Part of Advanced Engineering Principles in Neuromodulation: Next-Generation SCS and DBS Technologies
Details
- Date
- Thursday, January 21, 2027
- Time
- 8:10 AM – 8:40 AM
- Session type
- Pre-Conference Session
- Schedule
- See this day
About
This course provides a deep dive into the advanced engineering behind next-generation spinal cord stimulation (SCS) and deep brain stimulation (DBS) technologies. The morning session spotlights academic leaders sharing foundational concepts critical to innovation in neuromodulation, covering topics such as implantable pulse generator design, electrode technology, novel stimulation paradigms, neural sensing, clinical testing strategies, and the integration of artificial intelligence. During the afternoon, you'll gain insider perspectives from engineers at top companies, as they present cutting-edge technologies recently launched or in active development. This unique structure bridges theory and application, empowering attendees with unparalleled insight into both the scientific fundamentals and real-world breakthroughs propelling neuromodulation forward. Each session features a dedicated faculty Q&A, offering direct engagement with experts. The course is tailored for a broad audience: neural engineers, clinicians, industry professionals, and researchers invested in advancing neuromodulation therapies. Attendees will explore the intricate engineering challenges of modern devices, discover emerging solutions and technologies, and understand how academic and industry innovators are shaping the future of patient care. Focused on the most relevant technological advancements and ongoing innovations, this course delivers practical knowledge that can immediately inform clinical decision-making, inspire new research directions, and support technology development in neuromodulation.
Presenters
-
Tim Denison, PhD
Royal Academy of Engineering Chair in Emerging Technologies
Institute of Biomedical Engineering, University of Oxford · Oxford
Professor Denison holds a joint appointment in Engineering Science and Clinical Neurosciences at Oxford, where he explores the fundamentals of physiologic closed-loop systems. Tim also serves as an advisor to several governments and industry boards for translational medical devices; in particular, helping define strategies for mapping scientific discovery to product development roadmaps within the regulatory and economic constraints of medical systems. To support translation to the clinic, he is a director and chief engineer of Amber Therapeutics, which designs, manufactures, and distributes the Picostim-DyNeuMo investigational research system that is active in multiple first-in-human device trials. Prior to Oxford, Tim was a Technical and Bakken Fellow at Medtronic PLC and Vice President of Research & Core Technology for the Restorative Therapies Group, where he helped oversee the design of next generation neural interface and algorithm technologies for the treatment of chronic neurological disease. In 2015, he was elected to the College of Fellows for the American Institute of Medical and Biological Engineering (AIMBE), and in 2024, he was named a Fellow of the Royal Academy of Engineering. He has an MS and PhD from MIT in electrical engineering, an AB in Physics and MBA from the University of Chicago.